CD4 and neoplasm: CD4+ T cell depletion completely ablated the tumor control efficacy of the NBTXR3 + XRT + PLT therapy, resulting in tumor growth and survival curves virtually indistinguishable from those of untreated controls (Fig. 2A–C).